GoKawiilChildren and teens with obesity and diabetes are increasingly turning to GLP-1 therapy, but given how much we still don't know about these revolutionary drugs, is that wise?
What Do We Actually Know About Kids on Weight-Loss Drugs?
Why This Matters
GLP-1 drugs are moving from adult weight-loss blockbusters into pediatric use, with more children and teens with obesity and diabetes being prescribed them. Because long-term data on growth, development and dependence is still thin, the shift raises real questions for families, clinicians and the companies and health systems scaling these treatments.
Key Takeaways
- GLP-1 prescribing is expanding to kids and teens with obesity and diabetes.
- Long-term safety and developmental effects in young patients remain poorly understood.
- The gap between fast adoption and slow evidence puts pressure on doctors, regulators and parents to weigh risks carefully.
Get alerts for these topics